Treatment for soft tissue sarcoma in childhood and adolescence Austrian results within the CWS 96 study

Wiener Klinische Wochenschrift

Volumn 117, Issue 5-6, 2005, Pages 196-209

  Modritz, Ditha ^a   Ladenstein, Ruth ^a,l   Pötschger, Ulrike ^a   Amman, Gabriele ^b   Dieckmann, Karin ^b   Horcher, Ernst ^b   Urban, Christian ^c   Meister, Bernhard ^d   Schmitt, Klaus ^e   Jones, Regina ^f   Kaulfersch, Wilhelm ^g   Haas, Hans ^h   Moser, Reinhard ⁱ   Stöllinger, Olaf ^j   Peham, Martina ^a   Gadner, Helmut ^a   Koscielniak, Ewa ^k   Treuner, Jörn ^k  

^a CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Universitatsklinik fur Kinder und Jugendheilkunde Graz   (Austria)

^d Universitatsklinik fur Kinder und Jugendheilkunde Innsbruck   (Austria)

^e KEPLER UNIVERSITY HOSPITAL   (Austria)

^f Landesklinik für Kinder und Jugendheilkunde Salzburg   (Austria)

^g GENERAL HOSPITAL KLAGENFURT   (Austria)

^h Kardinal Schwarzenberg'sches Krankenhaus Schwarzach   (Austria)

ⁱ Landeskrankenhaus   (Austria)

^j Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

^k OLGAHOSPITAL   (Germany)

^l ST ANNA CHILDREN S HOSPITAL   (Austria)

more..

Author keywords

Adolescent; Austria; Child; Combined modality therapy; Soft tissue sarcoma

Indexed keywords

BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IDARUBICIN; IFOSFAMIDE; MELPHALAN; THIOTEPA; TROFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRIA; BLADDER CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL PROTOCOL; FEMALE; FIBROMATOSIS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INFANT; LIMB TUMOR; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; NEWBORN; OUTCOMES RESEARCH; PARAMENINGEAL DISORDER; PATIENT SELECTION; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE; RHABDOMYOSARCOMA; RISK ASSESSMENT; SOFT TISSUE SARCOMA; SURVIVAL RATE; UROGENITAL TRACT CANCER;

ADOLESCENT; ADULT; AUSTRIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SARCOMA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 20844457624     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-004-5-0285-8     Document Type: Article

References (28)

1. Koscielniak E, Treuner J, Jurgens H, Winkler K, Burger D, Herbst M, Ritter J, Niethammer D, Muller-Weihrich S, Bernhard G (1991) Treatment of soft tissue sarcomas in childhood and adolescence: results of the CWS-81 multicenter therapy study. Klin Padiatr 203: 211-219
2. Koscielniak E, Jurgens H, Winkler K, Burger D, Herbst M, Keim M, Bernhard G, Treuner J (1992) Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study. Cancer 70: 2557-2567
3. Koscielniak E, Harms D, Henze G, Jurgens H, Gadner H, Herbst M, Klingebiel T, Schmidt BF, Morgan M, Knietig R, Treuner J (1999) Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 17: 3706-3719
4. Lawrence W Jr, Gehan EA, Hays DM, Beltangady M, Maurer HM (1987) Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II). J Clin Oncol 5: 46-54
5. Maurer HM, Beltangady M, Gehan EA, Crist W, Hammond D, Hays DM, Heyn R, Lawrence W, Newton W, Ortega J, et al (1988) The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer 61: 209-220
6. Klingebiel T, Koscielniak E, Pilz T, Krümpelmann S, Boos J, Treuner J (2000) High dose therapy versus oral maintenance: interim result of HD CWS 96 study for treatment of patients with metastasized soft tissue sarcoma. Bone Marrow Transplant 25 [Suppl 1]: 245
7. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
8. Mantel N (1966) Evaluation of survival data and two new rank order situations arising from its consideration. Cancer Chemother Rep 50: 163-170
9. Treuner J, Koscielniak E, Keim M (1989) Comparison of the rates of response to ifosfamide and cyclophosphamide in primary unresectable rhabdomyosarcomas. Cancer Chemother Pharmacol 24 [Suppl 1]: S48-50
10. Maurer HM, Gehan EA, Beltangady M, Crist W, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J, et al (1993) The Intergroup Rhabdomyosarcoma Study-II. Cancer 71: 1904-1922
11. Crist WM, Garnsey L, Beltangady MS, Gehan E, Ruymann F, Webber B, Hays DM, Wharam M, Maurer HM (1990) Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee. J Clin Oncol 8: 443-452
12. Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J, Heyn R, et al (1995) The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13: 610-630
13. Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Brenemann J, Qualman S, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS (2001) Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 19: 3091-3102
14. Flamant F, Rodary C, Rey A, Praquin MT, Sommelet D, Quintana E, Theobald S, Brunat-Mentigny M, Otten J, Voute PA, Habrand JL, Martelli H, Barrett A, Terrier-Lacombe MJ, Oberlin O (1998) Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer 34: 1050-1062
15. Ferrari A, Casanova M, Bisogno G, Zanetti I, Cecchetto G, De Bernardi B, Ricardi R, Tamaro B, Meazza C, Alaggio R, Ninfo V, Carli M (2003) Rhabdomyosarcoma in infants younger than one year old: a report from the Italian Cooperative Group. Cancer 97: 2597-2604
16. Friedman DL, Meadows AT (2002) Late effects of childhood cancer therapy. Pediatr Clin North Am 49: 1083-1106
17. Schwartz CL (1999) Long-term survivors of childhood cancer: the late effects of therapy. Oncologist 4: 45-54
18. Koscielniak E, Herbst M, Niethammer D, Treuner J (1994) Improved local tumor control by early and risk-adjusted use of radiotherapy in primary non-resectable rhabdomyosarcomas: results of CWS 81 and 86 studies. Klin Padiatr 206: 269-276
19. Schuck A, Mattke AC, Schmidt B, Kunz DS, Harms D, Knietig R, Treuner J, Koscielniak E (2004) Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary? J Clin Oncol 22: 143-149
20. Ladenstein R, Treuner J, Koscielniak E, d'Oleire F, Keim M, Gadner H, Jurgens H, Niethammer D, Ritter J, Schmidt D (1993) Synovial sarcoma of childhood and adolescence. Report of the German CWS-81 study. Cancer 71: 3647-3655
21. Okcu MF, Munsell M, Treuner J, Mattke A, Pappo A, Cain A, Ferrari A, Casanova M, Ozkan A, Raney B (2003) Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. J Clin Oncol 21: 1602-1611
22. Klingebiel T, Koscielniak E, Beske F, Boos J, Mattke A, Brecht I, Treuner J (2003) High dose therapy versus oral maintenance: results of HD CWS 96 study for treatment of patients with metastasized soft tissue sarcoma. Med Pediatr Oncol 41(4): 278
23. Koscielniak E, Klingebiel TH, Peters C, Hermann J, Burdach ST, Bender-Gotze C, Muller-Weihrich ST, Treuner J (1997) Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. Bone Marrow Transplant 19: 227-231
24. Carli M, Colombatti R, Oberlin O, Stevens M, Masiero L, Frascella E, Koscielniak E, Treuner J, Pinkerton CR (1999) High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma. J Clin Oncol 17: 2796-2803
25. Atra A, Pinkerton R (2002) High-dose chemotherapy in soft tissue sarcoma in children. Crit Rev Oncol Hematol 41: 191-196
26. Ferrari A, Casanova M, Bisogno G, Cecchetto G, Meazza C, Gandola L, Garaventa A, Mattke A, Treuner J, Carli M (2002) Malignant vascular tumors in children and adolescents: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group. Med Pediatr Oncol 39: 109-114
27. Ferrari A, Casanova M, Bisogno G, Mattke A, Meazza C, Gandola L, Sotti G, Cecchetto G, Harms D, Koscielniak E, Treuner J, Carli M (2002) Clear cell sarcoma of tendons and aponeuroses in pediatric patients: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group. Cancer 94: 3269-3276
28. Ferrari A, Casanova M, Bisogno G, Mattke A, Meazza C, Gronchi A, Cechetto G, Fidani P, Kunz D, Teuner J, Carli M (2001) Hemangiopericytoma in pediatric ages: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group. Cancer 92: 2692-2698